⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15621087 | 0.74 | — | — | |
| SCHEMBL12814546 | 0.70 | GRM4 (0.32) | — | |
| SCHEMBL12814320 | 0.64 | — | — | |
| Hydrochloric Acid SCHEMBL935838 | 0.60 | — | — | |
| SCHEMBL133552 | 0.60 | BACE1 (0.30) | — | |
| SCHEMBL16699727 | 0.60 | BACE1 (0.30) | — | |
| SCHEMBL1535715 | 0.60 | — | — | |
| Hydrochloric Acid SCHEMBL547963 | 0.60 | — | — | |
| SCHEMBL1535723 | 0.59 | BACE1 (0.31) | — | |
| SCHEMBL4903074 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2688921-A2 | DIBLOCK COPOLYMERS PREPARED BY CROSS METATHESIS | Exxonmobil Chemical Patents Inc. (US) | 2014-01-29 | — | — | EP | disclosed |
| EP-2688954-A2 | OLEFIN TRIBLOCK POLYMERS VIA RING-OPENING METATHESIS POLYMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2014-01-29 | — | — | EP | disclosed |
| WO-2013158225-A1 | POLYOLEFIN COMPOSITIONS AND METHODS OF PRODUCTION THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-10-24 | — | — | WO | disclosed |
| WO-2012134713-A2 | OLEFIN TRIBLOCK POLYMERS VIA RING-OPENING METATHESIS POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012134722-A2 | DIBLOCK COPOLYMERS PREPARED BY CROSS METATHESIS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-10-04 | — | — | WO | disclosed |